by qfrsolutions | Aug 31, 2015 | News
Source: Biotech stocks have been one of the market’s hottest spots in recent years. But when markets get a sudden chill, as they did this month, big pharmaceutical shares are a better bet. Over the past four years, a broad index of biotech stocks has...
by qfrsolutions | Aug 26, 2015 | News
Source: Forbes Last week I wrote a post about new data from BioMedTracker that show that the Food and Drug Administration, which once approved as few as 40% of new drugs submitted by industry, has been on a green-light-almost-everything jag, approving 89% of drug...
by qfrsolutions | Aug 6, 2015 | News
Source: FierceHealthPayer The biggest for-profit health insurers continue to benefit from a low utilization trend among consumers, as most reported better-than-expected second-quarter earnings. The weak economy keeps consumers from seeing their doctors and avoiding...
by qfrsolutions | Aug 5, 2015 | News
Source: Drug sales crossed a significant metric last year. They grew past $1 trillion. And for those industry insiders thinking global sales will taper off, a new report says think again. Expect sales to top $1.3 trillion in 2018. Recent years have been full of...
by qfrsolutions | Jul 27, 2015 | News
Source: At age 45, Allergan Chief Executive Brent Saunders already pulled off something like $150 billion worth of deals. Now he’s going to get ready to do it again. Last year alone Saunders was credited with an amazing $97 billion worth of mergers and...
